Breaking News on Global Pharmaceutical Technology & Manufacturing

Mergers and acquisitions

The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.

Oral Dose Competition Intensifies as Qualicaps Expands Manufacturing

26-Feb-2013 - Following a bout of investments, the oral dose solution market has been described as “competitive” and “dynamic” by two of the major players.

IMCD Buys Indian Distributor Indchem for Pharma business

20-Feb-2013 - Chemical distributor IMCD Group says acquisition of Mumbai-based Indchem will build its presence in the Indian pharmaceutical excipient sector.

Unichem Sell Indian Formulation Plant to Mylan

19-Feb-2013 - Mylan Laboratories has purchased a new finished formulations facility in an Indian Special Economic Zone from Unichem Laboratories.

Merck: ‘In-House API Production Remains Important Strategy’

14-Feb-2013 - Merck says it will keep in-house API production capacity as it continues to evaluate its manufacturing strategy.


Teva to Sell Californian Plant as Part of Cost-Cutting Initiative

11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.

News in brief

Sun Takeover Bid Burns Out as Taro Grows

11-Feb-2013 - Sun Pharmaceutical Industries has abandoned its long running efforts to buy Israel’s Taro, explaining the move is in the best interest of shareholders.

breaking news - update

BASF sees synergies between new acquisition Pronova and Equateq

21-Jan-2013 - BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.

Exclusive - update

Odin likely to accept revised offer for Pronova says BASF

18-Jan-2013 - German chemicals giant BASF expects its revised takeover bid for Norwegian omega-3 API manufacturer Pronova Biopharma ASA to be accepted by resistant shareholders.


Greece is the word: BASF tells Pronova shareholders revised bid is fair value

15-Jan-2013 - BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs. 

Symrise-Probi partnership to deliver probiotic goods in 2014-15

20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...

Equateq, Cognis and Pronova: “Each are complementary”, says BASF

26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.

CPhI Worldwide 2012: Networking, up-coming countries and bioavailability

08-Oct-2012 - is going to Madrid, Spain to meet API and excipient makers, Biopharma firms, processing tech developers and contract services organisation gathered for one of the drug industry's biggest trade shows....

BD hunting "plug in" acquisitions

07-Aug-2012 - BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.


Invest in African R&D to boost manufacturing: WAPMA and PMGMAN's plea

23-Jul-2012 - WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.

Less regulatory pressures, more growth: say top pharma execs

09-Jul-2012 - Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.

Bosch plans to upscale its new X-ray capsule QC tech

28-Jun-2012 - Bosch Packaging says it is now developing a big batch version of its new X-ray capsule inspection tech.


Pakistan's re-joined health ministry still troubled, says PPMA

27-Jun-2012 - PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.

Lack of “horsepower” prompts sale of AMPAC aerospace biz

06-Jun-2012 - AMPAC is selling its aerospace business after deciding it lacked the “horsepower” to grow both it and the pharmaceutical unit.


GDUFA means a level playing field for generics makers, says SOCMA

04-Jun-2012 - The new Generic Drugs User Fee Act (GDUFA) means a “level playing field” for drugmakers, according to SOCMA members.

Aptar to enter injectable device components with €165m buy

04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.

P-Gels mean cheaper and more varied drug development, says Patheon

31-May-2012 - Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.

Mergers a “key problem” for regulatory compliance, drug quality expert says

29-May-2012 - Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.

Manufacturing expansions round-up

12-Apr-2012 - in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans...

Cambrex on takeover hunt amid pharma fine chem consolidation

08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.

Key Industry Events

Interphex 2014

New York, NY 10001 / Conference and exhibition

Read more

Access all events listing